Job Elders is managing partner at Greenfield Capital Partners. He is a serial entrepreneur focusing on technology companies, industrial and B2B companies in growth stage. Dr. Elders serves as chairman of the board of Solmates B.V. (NL) and Micronit B.V. (NL) and as advisor of Zenzium Inc. (MA, USA), 747 Stuyvesant fund IV and 747 Capital Hudson funds (NY, USA). In addition, Dr. Elders is founder and board member of the Kipaji scholarship fund of the University of Twente, board member of Eric Bleumink foundation of the University of Groningen and board member of the Greenfield foundation. He is the author of more than 80 technical and business publications as well as patents and has chaired and spoken at several investor events and MEMS (Micro Electro Mechanical Systems) events.
Previously, he has founded and/or developed five technology companies and was executive director of Enschede Innovation Fund. He invested in Xsens Holding B.V. and served as director until its acquisition by Fairchild Semiconductor Limited (NASDAQ, FCS) in 2014. With Greenfield Capital Partners as investor, Dr. Elders was founder and CEO of C2V until its acquisition (Thermo Fisher Scientific, NYSE, TMO) in 2009. He was founder of TMP in the mid nineties and served as TMP’s Managing Director until its acquisition by Kymata Ltd and served as Vice President and General Manager of Alcatel Optronics Netherlands after Alcatel’s (NYSE, ALU) acquisition of the operations in 2001. Dr. Elders was founder and board member of the MANCEF foundation as well as founder of the Point One foundation and member of its board until 2010. He was chairmen of the board of Encapson B.V. untill 2016.
Dr. Elders received his Ph.D. in Physical Chemistry from the University of Amsterdam.